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In nature, bacteria are constantly exposed to many 
stressful conditions of life. This is particularly true of 
pathogens. Survival and adaptation under stressful 
conditions demand multiple strategies, genetic as well 
as phenotypic. Bacteria have many, pre-programmed, 
phenotypic stress response systems which can handle 
a limited number of stresses. Genetically, heritable as 
well as transient hypermutability mechanisms have 
been found to facilitate bacterial adaptation to varied 
and unpredictable stresses; these processes are not  
reviewed here. Instead, this article will focus on pro-
cesses which do not increase global mutation rates but 
cause localized hypermutability in specific loci called 
contingency genes which have been identified particu-
larly in pathogenic bacteria. These processes are col-
lectively called phase and antigenic variations. Most of 
the contingency genes are involved in the synthesis or 
modification of surface-associated structures and en-
zymes. Phase variation in these genes involves high 
frequency, reversible, switching of their expression 
(on to off and off to on). The mechanisms of this 
switching are reviewed. However, some phase variable 
genes are not involved in the synthesis or modification 
of surface structures but are components of type I and 
type III restriction–modification (RM) systems. The 
on/off switching of these genes (type III RM genes) 
leads to regulation of expression of many unlinked 
genes, impacting several properties of cells. This novel 
type of control of multiple gene expression by phase 
variation has been named ‘phasevarion’. The adaptive 
advantages of phase variation in contingency genes 
and phasevarions in the evasion of host immunity, 
virulence, niche adaptation and other phenomena are 
reviewed with some illustrative examples. Phase varia-
tion and bacterial adaptation have been likened to the 
‘Red Queen’s Race’ in Lewis Carrol’s classic Through 
the Looking Glass. 
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THE life of bacteria in nature is plagued by struggle for 
survival, perpetuation and evolution. Bacteria are  
constantly subjected to various stresses such as heat, star-
vation, oxidative stress, DNA damage, exposure to radia-
tion, toxic agents, etc. Phenotypically, bacteria respond to 
stress by modulation of gene expression through sigma 
factors, proteolysis and other mechanisms. There are sev-
eral well-documented mechanisms of stress responses 
which have been extensively reviewed1–7. These pre-
programmed response systems enable organisms to sense, 
respond and adapt to stress. Some of them also result in 
concomitant mutagenesis which has been categorized as 
stress-induced mutagenesis7,8. However in nature, stresses 
encountered by bacteria are many in number and variety, 
and are often unpredictable and unprovoked. In the  
absence of any pre-determined mechanisms to handle 
such exigencies, the survival of bacteria is endangered. 
Obviously, it is not possible to evolve and maintain  
response mechanisms to each and every conceivable 
stress. Unforeseen challenges could be best countered by 
genetic strategies, that is, through mutations and/or hori-
zontal gene transfer. Since spontaneous mutation rates are 
usually very low, adaptation through spontaneous muta-
tions is difficult to achieve, although not impossible. Ele-
vation of mutation rates (hypermutability) would be a 
very efficient means to generate genetic diversity and ac-
celerate the speed of adaptation. It is not difficult to un-
derstand that when multiple mutations are required for 
adaptation, hypermutators would be better endowed than 
normo-mutators since the former can generate many  
mutations, some of which could be adaptively advanta-
geous. For example, during infection, pathogens face 
multiple bottlenecks in the form of host defences, antibi-
otic intervention, inter-host and inter-tissue transmis-
sions, competition by co-infecting organisms and/or 
commensals, etc. to succeed in establishing successful in-
fection. Survival and growth under such conditions de-
mand multiple mutations and hypermutators could easily 
meet such demands. It is, therefore, not surprising that 
clinical isolates of many pathogens such as Escherichia 
coli, Salmonella species, Pseudomonas aeruginosa, 
Haemophilus influenzae, Streptococci, Staphylococci, 
Neisseriae, Helicobacter pylori, etc. contain high propor-
tions of hypermutators (1–30%)9–12. The mechanisms of 
hypermutability have been reviewed13. While hypermuta-
bility can be an asset to organisms since it enables easy 
adaptation, it can also be a liability. A majority of muta-
tions happen to be deleterious and only very few are 
adaptively beneficial. It has been estimated that in E. coli, 
the mutation rates for deleterious mutations are generally 
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10–5–10–4/cell/generation14,15, whereas the rates for bene-
ficial mutations are 4–5 orders of magnitude less16. 
Therefore, hypermutability is inevitably associated with 
an enhanced risk of accumulation of many unwanted and 
deleterious mutations, especially if the trait persists after 
adaptation. In spite of such risks, hypermutability is quite 
common in nature (see above). Apparently, the adaptive 
benefits of hypermutability outweigh the disadvantages 
that might accrue due to deleterious mutations. Moreover, 
when a mutator cell adapts to a stress and grows by  
acquiring a beneficial (adaptive) mutation, the mutator 
mutation ‘hitch hikes’ with the adaptive mutation and is 
inherited, a phenomenon called indirect or second-order 
selection. Obviously, hypermutability without risks 
would be ideal for adaptation. Two processes exist which 
can accomplish this. One is transient hypermutability 
which is implicated in the mutagenic processes associated 
with stress responses. Here, the mutagenic potential does 
not persist after adaptation and therefore there is no long-
term risk. Transient hypermutation (variously called 
adaptive mutagenesis, stationary phase mutagenesis, 
stress-induced mutagenesis, post-plating mutagenesis, 
etc.) will not be discussed here. Several excellent reviews 
and reports on this topic have appeared in recent 
years7,8,17–23. The other mechanism of risk-free hypermu-
tation is localized hypermutation in which mutagenesis is 
restricted to certain loci called ‘contingency’ genes. This 
review will focus on this process which underlies the 
phenomena called phase and antigenic variations. 
Contingency genes and phase variation 
Phase variation was first recognized in strains of Salmo-
nella in the early 1920s by the discovery of switching  
between two flagellar antigenic types, initially detected 
as variants in colony morphology. The molecular mecha-
nisms of this and similar phenomena began to be unrav-
elled half a century later. The term ‘phase variation’ is 
used to denote the high frequency, reversible, on/off 
switching of the expression of one or more genes, which 
(usually) encode or modify surface associated structures/ 
components such as fimbriae/pili, lipopolysaccharides, 
lipoproteins, membrane proteins, iron acquisition proteins, 
surface enzymes, etc. The frequency of this reversible 
switching (10–4–10–3/cell/generation) in either direction is 
several fold higher than spontaneous mutation frquencies 
and leads to the presence or absence of the surface struc-
ture(s), encoded by the respective gene(s) (see below for 
references). As will be discussed in detail below, phase 
variation is an efficient means of generating population 
diversity and helps organisms, especially pathogens, in 
many ways such as survival in fluctuating environments, 
niche adaptation, virulence, evasion of host immune re-
sponse, etc. Phase variable genes are called ‘contingency’ 
genes, as opposed to normal, ‘house-keeping’ genes. 
They have been found in many bacterial pathogens such 
as H. influenzae, Neisseria meningitidis, Neisseria gonor-
rhoeae, Bordetella pertussis, species of Mycoplasma, H. 
pylori, etc. just to name a few; their biology has been  
reviewed extensively24–30. The most common type of con-
tingency genes present in many bacteria are characterized 
by the presence of varying numbers of contiguous, simple 
sequence repeats, or homopolymeric nucleotide tracts of 
varying lengths (also called microsatellites). These motifs 
are found within protein-coding sequences or in the pro-
moter region (in between the –35 and –10 sequences) or 
downstream of the promoter before the translation start 
codons or upstream of the promoter where the accessory 
transcription factors act. (In some cases, they are found 
very much upstream of promoters; see below.) A mecha-
nism called ‘slipped strand mispairing (SSM)’ has been 
suggested to explain the reversible on/off switching of 
the contingency genes25,31,32. SSM can occur during proc-
esses which involve DNA synthesis (replication, repair, 
recombination, etc.). It is believed that during DNA syn-
thesis, the template and nascent DNA strands separate 
transiently and reanneal. During reannealing, the nascent 
strand can slip forward or backward on the template 
strand. This will result in the formation of a ‘bulge’ either 
in the template strand (due to forward slipping) or in the 
nascent strand (due to backward slipping), leading to the 
contraction or expansion, respectively, of the length of 
the repeat tracts in the next round of replication25,31. De-
pending on the location of the repeat sequences, tran-
scription and/or translation of the genes could be affected 
in many ways when this event (phase variation) occurs. 
Some of the possible outcomes of SSM are: reduction/ 
abolition of promoter activity, loss/reduction of accessory 
factor binding, generation of frameshift mutations leading 
to the synthesis of altered proteins or, more commonly, 
generation of premature termination (nonsense) codons. 
 Since most of the contingency genes encode surface-
associated structures or components32, the progeny cells 
will lack them when their expression is turned off by 
phase variation. A clonal population of cells will, there-
fore, consist of sub-populations in which the contingency 
genes will be in the on/off states of expression. Since the 
frequencies of switching are high and cells can have mul-
tiple contigency genes, it is possible to generate enor-
mous population diversity by phase variation. (If there 
are n contingency loci in a cell, each of which could exist 
in the on/off states of expression, the number of possible 
sub-populations will be 2n). As discussed below, such 
population diversity is extremely useful in adapting to 
stress, evasion of host immune response, modulation of 
virulence and many other processes. Although SSM is the 
most common mechanism of phase variation, it is not the 
only one. Others include homologous recombination, site 
specific recombination, transposon insertion/excision  
and differential DNA methylation. Novel mechanisms  
of phase variation are also coming to light. Extensive  
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literature on each of these processes is available. Due to 
space constraints, only a brief description of the salient 
features of these processes will be presented below, citing 
a limited number of examples. An exhaustive review by 
van der Woude and Baumler32 is an excellent source for 
most of the information. 
Other mechanisms of phase variation 
Homologous recombination 
Homologous recombination is associated with a process 
called ‘antigenic variation’, which is similar but not iden-
tical, to phase variation. Phase variation determines the 
presence or absence of one or more surface-associated 
cellular structure(s). In antigenic variation, only one form 
of a given antigen is present on the cell surface at any 
given time although the cell has the genetic potential to 
synthesize a family of that particular antigen (reviewed 
by van der Woude and Baumler)32. The best studied  
example of homologous recombination-mediated anti-
genic variation is pilin variation in N. gonorrhoeae33. 
This event occurs at a very high frequency (10–4 or more/ 
cell/generation) and involves homologous recombination 
between a transcriptionally active pilE gene copy and one 
of the many (up to 6), transcriptionally silent, pilS gene 
copies, generating variation in pilE sequences without 
any change in the pilS sequences. Antigenic variation in 
the pilE gene of N. gonorrhoeae requires the products of 
recA, recF and recX genes. This is actually a process of 
gene conversion, the molecular details of which have 
been reviewed33. Similar to phase variation, antigenic 
variation also results in the generation of antigenically 
diverse subpopulations and helps in adaptation (evasion 
of host immunity; see below). Antigenic variation has 
been documented in several bacteria32. 
Site-specific recombination 
The process of site-specific recombination in relation to 
phase variation has also been called conservative site-
specific recombination. In this process, the inversion 
(flipping) of a short DNA segment harbouring the pro-
moter of a phase variable gene results in expression of the 
gene in one orientation and non-expression in the other. 
A well-documented example of this process is the phase 
variation of the fimA gene, encoding type 1 fimbriae, in 
uropathogenic E. coli (UPEC). A short (~300 bp) invert-
ible DNA segment intervenes fimA and two other genes 
(fimB and fimE) which encode two site-specific recombi-
nases. In one orientation of the invertible segment the 
promoter of fimA is correctly positioned for its expression 
but not in the other. The flipping of this segment, mediated 
by the site-specific recombinases, results in the on/off 
switching of fimA and consequent phase variation. The 
flipping requires several other factors besides the recom-
binases (reviewed by van der Woude and Baumler32; also 
see ref. 35). The adaptive benefits due to fim phase varia-
tion are discussed in a later section. 
Transposition 
Phase variation mediated by insertion and excision of 
transposable elements is known to occur but restricted 
only to a few IS elements32. Generally, transposons have 
no target specificity in insertions, and excisions are almost 
always imprecise. However in a few instances insertions 
have been shown to be target-specific and excisions to be 
precise. Examples are transposon-mediated phase variation 
in the eps gene of Pasteurella atlantica (a marine organ-
ism) by the transposon IS492, the cca gene of Staphylo-
coccus epidermidis by IS2561 (reviewed by van der 
Woude)32. Phase variation in capsule synthesis in N. men-
ingitidis by the precise insertion and excision of IS1301 
in the siaA (sialic acid biosynthesis) gene has been shown 
(see below). 
GATC methylation 
Phase variation by mechanisms involving DNA adenine 
methylase (Dam)-catalysed GATC methylation are well 
documented. A well characterized example is the phase 
variation of the pyelonephritis associated pili (pap) op-
eron of UPEC34. In this case, the on/off state of the 
papBA genes is determined by differential binding of two 
proteins, Pap I and the leucine-responsive regulatory pro-
tein (Lrp), at one of the two GATC sites, one proximal to 
the promoter and the other distal to it. Binding of these 
proteins at one site blocks methylation at that site and 
leaves the other site open for methylation. When methyla-
tion occurs at the promoter proximal GATC site (Lrp and 
PapI bound at the promoter distal site), the operon gets 
into the on state, assisted by cyclic AMP-CAP (catabolite 
activator protein) complex. When methylation at the 
promoter proximal site is blocked by the binding of Lrp, 
the promoter distal GATC gets methylated and the ex-
pression is turned off. The above is an over-simplified 
description of the switching process which has been re-
viewed extensively32,34,35. Another example of GATC me-
thylation-dependent phase variation is that of the flu gene 
of E. coli which encodes the multifunctional outer mem-
brane protein Ag43, involved in cell aggregation, biofilm 
formation and phage adsorption. The regulatory region of 
flu has three GATC sites and the oxidative stress re-
sponse protein OxyR is a repressor of its expression. 
When OxyR is bound at its binding site, the GATC sites 
are masked and hence the Dam methylase cannot access 
the sites. This turns the expression to the off state. When 
the GATC sites are methylated, binding of OxyR is 
blocked and the expression is turned on. Therefore the 
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on/off transition is determined by a stochastic, concentra-
tion-dependent competition between Dam methylase and 
OxyR for binding to the control site of flu32,36. It should 
be noted that the mechanism of phase variation outlined 
above is epigenetic since no changes in DNA sequences 
are involved but the expression states (on/off) are herita-
ble36. The phase variation of pap described above is also 
epigenetic. These two systems are the only ones docu-
mented so far in this class of phase variable genes. 
Phase variation driven by a ligand-sensitive  
repressor 
A novel phase variable gene, viz. nadA, was reported by 
Martin et al.37 in N. meningitidis. This gene has a tetranu-
cleotide (TAAA) repeat motif (not reported earlier in 
phase variable genes of this organism), upstream of the  
–35 region of its promoter. Martin et al.37 showed that the 
level of expression of nadA was dependent on the length 
of the repeat tract, being high (13, 10 and 8 repeats), or 
medium (11 and 12 repeats) or low (9 repeats). (In a sub-
sequent report, it was shown that nadA encodes an adhesin/ 
invasin, implicated in the pathogenicity of N. meningiti-
dis; see below.) Metruccio et al.38 reported the molecular 
mechanism of phase variation of nadA. They identified (i) 
a cis-acting regulatory region, named growth phase regu-
latory (GPR) region, located between –108 and –170 bp 
with respect to the nadA transcription start site and (ii) a 
protein, named NadR (encoded by the gene nadR) which 
binds to GPR and represses the expression of nadA. The 
repressor activity of NadR was observed to be influenced 
by the length of the tetranucleotide repeat motif. More-
over, they also showed that 4-hydroxyphenyl acetic acid, 
a product of aromatic aminoacid catabolism, inhibited 
NadR binding to the nadA operators, thereby derepress-
ing (inducing) nadA expression. This is a novel mecha-
nism of phase variation. Interestingly, the upstream 
regions of virulence genes of some other pathogens have 
been shown to contain repeat sequences, some of which 
also phase vary (for references see Metruccio et al.38) but 
the mechanistic details are not known. 
Phase variation in genes encoding restriction–
modification (RM) enzymes: Phasevarions 
Generally, phase variable genes encode surface-associa-
ted cellular components. However, the repeat sequence 
motifs, characteristic of phase variable genes, have also 
been found in genes which are not obvious candidates to 
encode any surface component(s). Well studied examples 
are the genes encoding restriction–modification (RM) en-
zymes in many pathogenic bacteria25,39,40 (also see refs 44 
and 64). Although some of these genes were experimen-
tally shown to phase vary (see below), many others were 
predicted to do so based on their DNA sequences. How-
ever, the functional role(s) of phase variation in these 
genes, remains obscure although several possibilities 
have been suggested (see below). Among the many-phase 
variable genes in strains of H. influenzae (listed by 
Moxon et al.25) the mod gene, encoding a DNA methyl 
transferase, is a component of a type III RM system. It 
was shown40,41 that phase variation in this gene is medi-
ated by a tetranucleotide repeat motif (AGTC in some 
strains and AGCC in some others). Using microarray ex-
pression analysis, Srikhanta et al.42 reported that inactiva-
tion of the mod locus in H. influenzae Rd resulted in 2–4 
fold-up regulation of seven genes and a similar down 
regulation of nine others. This is perhaps the first report 
of a global regulatory role for a phase variable gene. This 
novel genetic system in which the expression of multiple 
and unlinked genes is regulated by phase variation in a 
member of the mod gene family was named ‘phasevarion’ 
(phase variable regulon)42. In a subsequent report,  
Srikhanta et al.43 reported that approximately 80 genes of 
N. meningitidis and N. gonorrhoeae were up/down regu-
lated by null mutations in their respective modA genes. 
Regulation of gene expression controlled by GATC me-
thylation, catalysed by the dam-encoded methylase, is a 
well-known phenomenon. But what distinguishes Dam 
methylase controlled regulation from the regulation by 
phasevarions is that, unlike mod, dam is not a phase vari-
able gene. Therefore, phasevarions seem to be unique and 
novel modes of control of gene expression. An up-to-date 
review on phasevarions has appeared recently44. 
 Phase variation in type I RM enzymes has also been 
shown in some strains of H. influenzae45,46. Wild type 
strains of H. influenzae Rd phase vary into two types 
which differ in their ability to restrict unmodified phage 
HPIcI: those which restrict (r+m+) and those which do not 
(r–m–). This transition has been shown to be mediated by 
the length of a pentanucleotide (GACGA) repeat motif, 
located at the beginning of the hsdM gene46. The r+m+ 
strains have 4 repeats whereas the r–m– variants have either 
3 or 5 repeats. Restriction of unmodified phages can only 
limit the extent of productive infection (reduction in burst 
size) but cannot confer total resistance which results from 
alteration of the structure of the receptors located on the 
cell surface. In H. influenzae, Rd30 resistance to phage 
HPIcI has been shown46 to occur by phase variation in the 
lic2A gene, resulting in the alteration of the surface lipoo-
ligosaccharide (LOS). Here, phase variation has been 
shown46 to be mediated by a tetranucleotide (CAAT) re-
peat motif in the gene, phage-sensitive strains having 22 
repeats and resistant ones having 21 repeats. The fre-
quencies of phase variation in the above cases is influ-
enced by mutation in the dam gene46. In the strain Rd118, 
switching from the r+m+ state to the r–m– state (on to off) 
and vice versa was approximately three-fold less in dam 
mutants. In the strain Rd30, however, phase variation 
from phage sensitivity to phage resistance (on to off) was 
approximately 10-fold higher in the dam mutant. Phase 
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variation to phage resistance could be adaptively benefi-
cial since phages exert strong selection pressure for sur-
vival. Unlike phase variation in type III RM systems, that 
in type I RM systems has not been shown to affect the 
expression of other, unlinked genes. 
Adaptive benefits of phase variation 
Phase and antigenic variations are usually looked upon, 
among other things, as a strategy deployed by pathogens 
to evade immune defence mechanisms mounted by their 
hosts. Although it is easy to visualize the role of anti-
genic variation in evasion of immune defence, extrapola-
tion of the same to phase variation is not so easy. The 
main difficulty is that bacteria lose a surface component 
when the gene involved in its synthesis phase varies to 
the off state and thus lack the function ascribed to it. 
However, this can also be looked upon as a blessing in dis-
guise because cells lacking one or more surface structures 
can effectively ‘hide’ themselves from attack by the 
host’s immune mechanisms36. Another problem to recon-
cile with is that phase variable genes have been found in 
many non-pathogens and non-host associated bacteria 
also32. Evasion of immune defence need not be the only 
use of phase variation; it could be a general strategy of 
stress adaptation. Population heterogeneity generated by 
phase variation could be useful in a more general way 
since there might be an assortment of cell types which 
could handle many kinds of stresses. The process could 
be viewed as an ‘insurance’ against catastrophe. In a sense, 
it is similar to bacterial persistence wherein a large popu-
lation of antibiotic sensitive cells contain a small fraction 
of antibiotic-tolerant (not resistant) cells (reviewed by 
Jayaraman47, and other references cited therein). Exten-
sive literature is available on the adaptive benefits of 
phase variation. These have been reviewed in depth by 
several authors30,32,35,48. Only a few illustrative examples 
will be described below. 
 A recent report by Bayliss et al.49 exemplifies the 
adaptive value of phase variation in evasion of host  
immunity. They showed that N. meningitidis strain 8047 
escaped the lethality due to a specific monoclonal anti-
body (MAbB5) when the gene lipopolysaccharide gluco-
syl transferase (lgtG) phase varied by losing a single C 
residue from a tract of 12 Cs in its reading frame, result-
ing in an out-of-frame to in-frame change (off to on 
switch). The consequent expression of lgtG leads to the 
incorporation of glucose in the inner core of the surface 
lipopolysaccharide (LPS) and loss of antibody sensitivity. 
When lgtG is off, phosphoethanolamine gets incorporated 
in place of glucose in the LPS and the cells are sensitive 
to killing by MAbB5. A mutation in a mismatch repair 
gene (Δ mutS) was found to greatly enhance the escape 
from antibody-mediated killing, probably by increasing 
the phase variation rate, thereby increasing the number of 
cells in the population permissive for translation of lgtG, 
prior to exposure to the antibody49. Phase variation in the 
lgtG gene has been shown to be enhanced in mutS  
mutants50. This is an elegant demonstration of how phase 
variation could impact the fitness of a pathogen by coun-
tering the immune defences of the host. Antigenic varia-
tion in pilE by homologous recombination33, described in 
an earlier section, is a very effective means of evading 
host immunity in N. gonorrhoeae. 
 Organisms belonging to the genus Mycoplasma, com-
prising many species, are among the smallest of free-
living microbes. Many of them are pathogenic for hu-
mans as well as non-human animals, producing persistent 
infections, even in the face of adequate host immunity. 
This has been shown to be due to their remarkable ability 
to undergo phase and antigenic variations which alter 
their surface architecture, resulting in successful escape 
from host immune responses51. What is remarkable is that 
even with their very small genome size they are as profi-
cient as bacteria with larger genomes in evading host 
immunity and maintaining infection. 
 In recent years, there has been a resurgence of pertussis 
(whooping cough), even in vaccinated populations. This 
indicates that the causative organism (Bordetella pertus-
sis) has developed mechanisms to evade host immune de-
fences, adapted to survive and cause disease. It is 
believed52 that phase variability could be an important 
mechanism in this phenomenon. 
 Phase variation has also been shown to influence bacte-
rial virulence and ability to initiate and maintain coloni-
zation of hosts during infection. A good example of this 
is provided by the study of niche adaptation in H. pylori. 
This organism has 31 phase variable genes (reviewed by 
Salaun et al.53). Phase variation in all the genes was 
monitored over a period of 150–360 days post-infection 
in a murine infection model54. It was observed that 10 of 
them phase varied at different times during the period, 
some early and some late. This suggested that phase 
variation determined not only the initial fitness for colo-
nization but also the subsequent niche adaptation. To cite 
another example, turning on the expression of the fimA 
gene by phase variation has been shown to be essential 
for establishment of urinary tract infections by uropatho-
genic E. coli (UPEC)55. Snyder et al.56 constructed mu-
tants of UPEC in which phase variation of the fim operon 
was ‘locked’ in the on/off states and examined their viru-
lence in a mouse infection model. The off-locked mutants 
were shown to be severely impaired in their ability to 
colonize the kidneys and bladder of mice whereas the on-
locked mutants were as virulent as the wild type strain, 
showing the importance of the on state of fim expression 
in pathogenicity. Since the on state is affected by phase 
variation it follows that phase variation is needed  
for pathogenicity. Klebsiella pneumoniae is another  
uropathogen but less pathogenic and less prevalent than 
UPEC. In a recent report57, it was shown that the reduced 
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pathogenicity of Klebsiella pneumoniae could be corre-
lated with reduced ability to turn on the expression of the 
fim operon by phase variation. A gene, fimK, was shown 
to reduce piliation, and the absence of a gene (fimX), encod-
ing a site-specific recombinase, were also shown to be 
contributing factors57.  
 Yet another mechanism linking phase variation to bac-
terial virulence has been reported in N. meningitidis. Usu-
ally, N. meningitidis resides as a commensal organism in 
the human nasopharynx. Occasionally, it turns virulent 
and enters the blood stream causing sepsis. From the 
blood stream it could cross the blood–brain barrier, infect 
the brain and lead to fatal meningitis. What triggers the 
transition to virulence is largely unknown but it occurs 
more frequently in some strains of N. meningitidis, called 
hyper-virulent strains, than others. A gene called Neisse-
ria Adhesin A (nadA) has been identified in some hyper-
virulent strains58. The NadA protein is a surface antigen 
which promotes adhesion to and entry into (invasion) 
epithelial cells. These properties were shown by E. coli 
also when nadA was expressed in them58. Inactivation of 
nadA reduced the ability to adhere and invade. These 
pathogenic properties could be correlated with phase viable 
expression of nadA. The novel mechanism of phase varia-
tion of nadA was described in an earlier section38. 
 N. meningitidis and N. gonorrhoeae have a family of 
outer membrane proteins called Opa (opacity-associated) 
proteins, encoded by a group of phase variable, inde-
pendently expressed, opa genes, numbering 3–4 in the 
former and 10–11 in the latter59,60. The Opa proteins are 
necessary for adhesion of the pathogen to host cells and 
also its internalization. These events involve the interac-
tion between host cell receptors and the Opa proteins59,60. 
Phase variation in the opa genes is very frequent (~10–3/ 
cell/generation) and involves pentameric (CTCTT) re-
peats in the coding sequences of the genes. Depending on 
the pattern of their expression, different cells in a popula-
tion will have different complements of Opa proteins  
resulting in population heterogeneity. Whereas phase 
variation in the pilin genes in Neisseriae could be linked 
to evasion of host immunity32,33, that opa genes could be 
linked to their invasiveness. A recent analysis of whole 
genome sequences of commensal and pathogenic strains 
of Neisseriae has revealed a high degree of similarity in 
the repertoire of virulence-associated genes between the 
two61. Interestingly, most of the commensal strains, with 
a few exceptions, lack the opa genes61. What are the criti-
cal determinants of the virulence/avirulence of Neisseriae 
is an area in which considerable research effort is focus-
sed currently61,62. There are other examples to show the 
link between phase variation and pathogenicity of Neisse-
riae (reviewed by Hill et al.63). For instance, turning off 
the production of capsule in N. meningitidis by SSM in 
the polyC tract of the siaD gene and/or IS1301 insertion 
in the siaA gene enhances the adhesion of the pathogen to 
target cells by fully exposing sub-capsular adhesins63. A 
good deal of information on meningococcal pathogenesis, 
not discussed here due to space constraints, can be found 
in the review by Hill et al.63. 
 As summed up by van der Woude48, ‘an encompassing 
view on the role of phase variation is that the generation 
of diverse sub-populations enhances the chance that at 
least one can overcome a stressful challenge, in essence a 
“hedge betting” strategy’. 
 Hypotheses on the adaptive advantages of phase varia-
tion in the mod genes of type III RM enzymes have cen-
tred around one of two possibilities, namely, DNA 
restriction activity or control of gene expression39–44,64. 
Many organisms which possess type III RM systems are 
naturally competent for DNA uptake and transformation. 
The presence of an active RM system will restrict incom-
ing heterologous DNA (via transformation, phage infec-
tion, horizontal gene transfer, etc.) since its function is 
considered to be protection of cells from foreign DNA. 
One of the possible roles suggested for phase variation in 
the RM systems is that their off state of expression might 
temporarily relax this barrier and permit the uptake and 
integration of foreign, but useful, DNA. Recently, a pro-
phage has been implicated in the invasiveness of N. men-
ingitidis65,66. It has been suggested39 that phase variation 
in the RM system of this organism might facilitate  
the horizontal spread of this phage among populations  
of Neisseriae, thereby enhancing their fitness (invasive-
ness). 
 A different role, namely, regulation of gene expression, 
has been proposed for phase variation in type III RM sys-
tems (see below). During a detailed analysis of the  
sequences of mod genes in various strains of H. influen-
zae, it was observed that the mod alleles could be 
grouped into 15 groups40. Strains belonging to three out 
of these 15 groups were found to be non-phase variable 
since they lacked the characteristic tetranucleotide repeats. 
Therefore, they cannot be considered to be part of any 
phasevarion and are probably dedicated solely to RM 
function. Among the strains possessing phase variable 
mod genes, 17% (7/41) had inactivating mutations in their 
res genes (encoding the restriction endonuclease)40. Fox 
et al.40 proposed that the RM system in strains possessing 
phase variable mod genes and nonfunctional res genes 
have evolved to function exclusively as regulators of 
gene expression, losing their original RM function. Al-
though obvious res mutations have been detected only in 
a few strains with phase variable mod genes, the possibi-
lity of yet undetected mutations, silencing the res in other 
strains cannot be ruled out40. Interestingly, none of the 
strains with non-phase variable mod genes had mutations 
in their res genes, supporting the notion that they are 
solely dedicated to RM function. In strains of N. meningi-
tidis and N. gonorrhoeae possessing phase variable mod 
genes, a majority (70%) had frameshift or deletion  
lesions in their res genes43. Wherever the genes of the 
RM system has evolved to function as regulators of gene 
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expression (phasevarions), phase variation in those genes 
can influence several properties such as virulence, anti-
biotic sensitivity, biofilm formation, nutrient uptake,  
response to stress, antigenic composition, etc.43. 
 If the mod gene of a strain is phase variable and if there 
is no inactivating mutation in the res gene (functional 
RM system), turning mod expression off will be inconse-
quential since Res will be functional only in association 
with Mod67 (also see figure 1 of ref. 44). However, when 
mod expression is turned on after several generations of 
growth in the off state (restoration of a functional RM 
system), a problem of suicidal, self restriction of the  
genome will arise. When such an event occurs, the genome 
will be initially unprotected (unmethylated) and will be 
susceptible to restriction when the active RM system is 
restored. Surprisingly, it has been possible to isolate an 
variants from off state cultures of strains which have no 
obvious res inactivating mutations (M. P. Jennings, pers. 
commun.). ‘Therefore Res is either inactive (via a non-
obvious silencing mutation) or has no lethal phenotype 
for some other reason’ (M. P. Jennings, pers. commun.). 
Another possibility is that since the contribution of type 
III RM system towards defence against foreign (unmodi-
fied) DNA is only marginal40, a good fraction of the 
population could survive. Nevertheless, this intriguing 
question awaits a definitive answer. 
Concluding remarks 
The success of adaptive evolution by natural selection 
depends upon how well organisms adjust and adapt to 
their environments. Bacteria, especially pathogens, en-
counter several unpredictable threats to their survival and 
are constrained to keep evolving adaptive strategies to 
tide over such threats. The threats also change and 
evolve. For example, pathogens would try many tricks to 
fool their hosts to establish themselves during infection. 
The hosts, in their turn, would try to come up with more, 
‘new and improved’, hurdles to contain and eliminate the 
invader. Thus, there is a constant coevolution of the 
threat and the response. This is likened68 to the Red 
Queen’s Race in Lewis Carrol’s classic, Through the 
Looking Glass in which the Red Queen tells Alice ‘It 
takes all the running you can do to keep in the same 
place. If you want to get somewhere else, you must at 
least run twice as fast’. In simple, layman’s language, 
stress and response could be compared to a predator and 
its prey, respectively. If the predator runs fast to catch the 
prey, the prey has to run faster to escape the predator. 
Evolutionarily speaking, phase variation (as well as heri-
table and transient hypermutability mechanisms, not dis-
cussed presently) empower bacteria to ‘run faster’ to deal 
with unforeseen and life-threatening stresses. The litera-
ture reviewed in the foregoing pages, though not exhaus-
tive, illustrates how bacteria exploit the power of phase 
variation to evolve counter offensive strategies for sur-
vival and perpetuation by generating genetic/population 
diversity. When a large population diversity is available it 
is possible that some among them could be adaptively 
useful and they could be taken advantage of to counter 
the threat. As pointed earlier, phase variation insures a 
cell population against challenges to survival. 
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